CN Patent

CN107721985A — 喹唑啉类酪氨酸激酶抑制剂的晶型

Assigned to Shandong Xuanzhu Pharma Co Ltd · Expires 2018-02-23 · 8y expired

What this patent protects

喹唑啉类酪氨酸激酶抑制剂的晶型。本发明属于医药领域，具体涉及一种Pan‑HER酪氨酸激酶抑制剂，即式(I)所示化合物(E)‑N‑(4‑((3‑氯‑4‑氟苯基)氨基)‑7‑甲氧基喹唑啉‑6‑基)‑4‑(2‑氮杂螺环[3.3]庚烷‑2‑基)‑2‑丁烯酰胺的晶型A、其制备方法、药物组合物，以及其在制备用于治疗和/或预防过度增生性疾病或慢性阻塞性肺病的药物中的应用。

USPTO Abstract

喹唑啉类酪氨酸激酶抑制剂的晶型。本发明属于医药领域，具体涉及一种Pan‑HER酪氨酸激酶抑制剂，即式(I)所示化合物(E)‑N‑(4‑((3‑氯‑4‑氟苯基)氨基)‑7‑甲氧基喹唑啉‑6‑基)‑4‑(2‑氮杂螺环[3.3]庚烷‑2‑基)‑2‑丁烯酰胺的晶型A、其制备方法、药物组合物，以及其在制备用于治疗和/或预防过度增生性疾病或慢性阻塞性肺病的药物中的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN107721985A
Jurisdiction
CN
Classification
—
Expires
2018-02-23
Drug substance claim
No
Drug product claim
No
Assignee
Shandong Xuanzhu Pharma Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.